YESCARTA

Kite Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 6, 2026
Approval ID: 9b70606e-b99c-4272-a0f1-b5523cce0c59
Products: 1 registered
Version: 23

Regulatory Information

Labeling Type

CELLULAR THERAPY

Status

Approved

Full Title

These highlights do not include all the information needed to use YESCARTA safely and effectively. See full prescribing information for YESCARTA. YESCARTA (axicabtagene ciloleucel) suspension for intravenous infusion Initial U.S. Approval: 2017

Quick Stats

Total Products1

Labelers1

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.